Virax Biolabs(us:VRAX)

1.00

-0.99%

Updated on 2025-06-10

Open:1.01
Close:1.00
High:1.04
Low:0.9811
Prev Close:1.01
Volume:29296.00
Turnover:29673.00
Turnover Ratio:0.67%
Shares:4.34M
MarketCap:4.34M

About Virax Biolabs

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Company Name: Virax Biolabs
Address: 20 North Audley Street
Employees: 11
Fiscar Year: 03-31
IPO Date: 2022-07-21
CIK: 1885827

View all SEC Filings

About

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Address:20 North Audley Street

Market Movers